{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T19:00:44Z","timestamp":1725735644324},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.diagmicrobio.2016.09.018","type":"journal-article","created":{"date-parts":[[2016,9,24]],"date-time":"2016-09-24T21:30:35Z","timestamp":1474752635000},"page":"372-376","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Correlation of clinical, laboratory and drug susceptibility profiles in 176 patients with culture positive TBM in a tertiary neurocare centre"],"prefix":"10.1016","volume":"86","author":[{"given":"Kavitha","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Giribhattanavar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagarathna","family":"Chandrashekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shripad","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.diagmicrobio.2016.09.018_bb0005","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00247-006-0319-7","article-title":"Distribution of brain infarction in children with tuberculous meningitis and correlation with outcome score at 6months","volume":"36","author":"Andronikou","year":"2006","journal-title":"Pediatr Radiol"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2016.09.018_bb0010","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1128\/JCM.39.12.4440-4444.2001","article-title":"Evaluation of BACTEC mycobacteria growth indicator tube (MGIT 960) automated system for drug susceptibility testing ofMycobacterium tuberculosis","volume":"39","author":"Ardito","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2016.09.018_bb0015","first-page":"1000","article-title":"Estimating mortality from tuberculous meningitis in a community: use of available epidemiological parameters in the Indian context","volume":"10","author":"Chakraborty","year":"2000","journal-title":"Prevalence"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2016.09.018_bb0020","first-page":"77","article-title":"Chloride content of the cerebrospinal fluid","volume":"94","author":"Gierson","year":"1961","journal-title":"Calif Med"},{"issue":"663","key":"10.1016\/j.diagmicrobio.2016.09.018_bb0025","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0140-6736(02)85622-7","article-title":"Tubercular meningitis","volume":"26","author":"Green","year":"1836","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2016.09.018_bb0030","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1473-3099(10)70138-9","article-title":"Tuberculous meningitis: a uniform case definition for use in clinical research","volume":"10","author":"Marais","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2016.09.018_bb0035","doi-asserted-by":"crossref","first-page":"716","DOI":"10.4103\/0028-3886.72178","article-title":"Tuberculous meningitis: the challenges","volume":"58","author":"Murthy","year":"2010","journal-title":"Neurol India"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2016.09.018_bb0040","first-page":"105","article-title":"Drug susceptibility profiling of tuberculous meningitis [short communication]","volume":"12","author":"Nagarathna","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2016.09.018_bb0045","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1128\/JCM.34.3.762-764.1996","article-title":"Evaluation of mycobacteria growth indicator tube for recovery and drug susceptibility testing of mycobacterium tuberculosis isolates from respiratory specimens","volume":"34","author":"Palaci","year":"1996","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2016.09.018_bb0050","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0962-8479(96)90032-5","article-title":"Significance of mycobacterial immune complexes (IgG) in the diagnosis of tuberculous meningitis","volume":"77","author":"Patil","year":"1996","journal-title":"Tuber Lung Dis"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2016.09.018_bb0055","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/15321819.2012.755630","article-title":"Comparative evaluation of ELISA and dot-blot for the diagnosis of tuberculous meningitis","volume":"34","author":"Patil","year":"2013","journal-title":"J Immunoassay Immunochem"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2016.09.018_bb0060","first-page":"1","article-title":"Diagnosis of tuberculous meningitis: challenges and promises","volume":"37","author":"Philip","year":"2015","journal-title":"Malays J Pathol"},{"key":"10.1016\/j.diagmicrobio.2016.09.018_bb0065","author":"Revised National TB Control Program (RNTCP)"},{"key":"10.1016\/j.diagmicrobio.2016.09.018_bb0070","series-title":"Mycobacteria growth indicator tube (MGIT) culture and drug susceptibility demonstration projects","article-title":"MGIT procedure manual. For BACTEC MGIT 960TB system (also applicable for manual MGIT)","author":"Siddiqi","year":"2006"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2016.09.018_bb0075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/jnnp.68.3.289","article-title":"Tuberculous meningitis","volume":"68","author":"Thwaites","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2016.09.018_bb0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/430616","article-title":"Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis","volume":"192","author":"Thwaites","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.09.018_bb0085","first-page":"169","article-title":"Chronic meningitis","author":"Wood","year":"1998","journal-title":"In Neurological infections; major problems in Neurology. Philadelphia: WB Saunders;"},{"key":"10.1016\/j.diagmicrobio.2016.09.018_bb0090","author":"World Health Organization"},{"key":"10.1016\/j.diagmicrobio.2016.09.018_bb0095","series-title":"Global tuberculosis report","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.diagmicrobio.2016.09.018_bb0100","article-title":"Outcomes and molecular profiles of drug resistance in tuberculous meningitis in non-HIV patients","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889316303170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889316303170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T07:23:54Z","timestamp":1601105034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889316303170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0732889316303170"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.09.018","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of clinical, laboratory and drug susceptibility profiles in 176 patients with culture positive TBM in a tertiary neurocare centre","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}